EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma

scientific article

EGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1001975561
P356DOI10.1186/1479-5876-9-168
P932PMC publication ID3198929
P698PubMed publication ID21970318
P5875ResearchGate publication ID51692856

P50authorClaudia Alexandra DumitruQ66360856
Robert L FerrisQ38328358
Sven BrandauQ39436389
P2093author name stringTheresa L Whiteside
Stephan Lang
Pedro A Andrade Filho
Edwin Boelke
Goetz F Lehnerdt
Jens Greve
Murat Bas
Patrick J Schuler
Petra Boeckers
Rainer Engers
Thomas K Hoffmann
P2860cites workFrequencies of tetramer+ T cells specific for the wild-type sequence p53(264-272) peptide in the circulation of patients with head and neck cancer.Q52012168
Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-BaseQ57949385
Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complexQ73205726
Development of a new diagnostic tool for pancreatic cancer: simultaneous measurement of antibodies against peptides recognized by cytotoxic T lymphocytesQ79819764
Lead and follow: the dance of the dendritic cell and T cellQ81020106
Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapyQ24596055
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neckQ29619277
Platinum-based chemotherapy plus cetuximab in head and neck cancerQ33381094
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trialQ34271566
Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.Q34554584
Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansionQ35125791
Signaling through the epidermal growth factor receptor during the development of malignancyQ35729447
Immune escape associated with functional defects in antigen-processing machinery in head and neck cancerQ36526586
Gefitinib (ZD1839, Iressa) as palliative treatment in recurrent or metastatic head and neck cancerQ36613924
Novel immunogenic HLA-A*0201-restricted epidermal growth factor receptor-specific T-cell epitope in head and neck cancer patientsQ36962838
Spontaneous apoptosis of tumor-specific tetramer+ CD8+ T lymphocytes in the peripheral circulation of patients with head and neck cancerQ37040545
Tricks tumors use to escape from immune controlQ37495211
A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltrationQ39885205
T cells specific for HPV16 E7 epitopes in patients with squamous cell carcinoma of the oropharynxQ40351911
Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.Q40500501
High steady-state levels of p53 are not a prerequisite for tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.Q40848769
Establishment and characterization of cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79.Q41715382
Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cellsQ44987437
A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifsQ45086654
P275copyright licenseCreative Commons Attribution 2.0 GenericQ19125117
P6216copyright statuscopyrightedQ50423863
P407language of work or nameEnglishQ1860
P304page(s)168
P577publication date2011-10-04
P1433published inJournal of Translational MedicineQ15716664
P1476titleEGFR-specific T cell frequencies correlate with EGFR expression in head and neck squamous cell carcinoma
P478volume9

Reverse relations

cites work (P2860)
Q50043038CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer
Q36806268Cetuximab-activated natural killer and dendritic cells collaborate to trigger tumor antigen-specific T-cell immunity in head and neck cancer patients
Q28069424Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment
Q45770749Immunotherapy of head and neck cancer. Current developments
Q38162129Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer
Q90390338OX40+ plasmacytoid dendritic cells in the tumor microenvironment promote antitumor immunity
Q36883848Promising systemic immunotherapies in head and neck squamous cell carcinoma
Q33872482Targeting CD137 enhances the efficacy of cetuximab.
Q38821915Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma
Q38161874The immune system and head and neck squamous cell carcinoma: from carcinogenesis to new therapeutic opportunities
Q36476100Trial watch: Peptide vaccines in cancer therapy

Search more.